Loading…
Gerresheimer AG will invest up to $94 million to expand its Morganton, North Carolina facility with new vial forming lines, increasing annual production capacity for Type 1 glass vials. The project is supported by BARDA with up to $66 million.
“Gerresheimer AG, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, today announced investments to rapidly expand its manufacturing, supply and logistics capability for glass vials in the U.S.”gerresheimer.com
Summarized from public sources; check the original articles before acting on it.